Clinical Trial Update: Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating endothelin receptor blockade in patients with ST-segment elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: Medical University of Vienna | Conditions: ST-Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED